Discover Eyetronic
Improve the field of vision
Improve the field of vision
Eyetronic therapy is a completely painless electrical stimulation of the optic nerve to halt the progression of glaucoma and in some cases improve the visual field
Eyetronic is an electrical stimulation of the optic nerve that can repair damaged nerve cells and protect them from further damage. The therapy is completely painless and has been proven by clinical studies.
The therapy includes ten sessions of 70-90 minutes each, which are carried out for 10 consecutive working days. The optic nerve is electrically stimulated using special glasses. The therapist adapts the treatment to the needs of the individual patient and monitors the progress of the therapy on a monitor.
Damage to the optic nerve does not completely damage the tissue, many cells survive but have a functional disorder.
Electrical stimulation prevents further loss of nerve cells and by exciting their metabolism promotes the restoration of their function.
Clinical studies have demonstrated the absence of significant side effects.
The electrical stimulation used for therapy is of very low intensity and can be adjusted if the patient perceives discomfort.
In some cases it is possible to develop a redness or irritation of the facial skin at the contact points with the electrodes which always resolves spontaneously.
It is possible to carry out one's activities normally before and after each therapy session.
Glaucoma is often not diagnosed early and when you start to notice a loss of details in the periphery it becomes difficult to stop the progression of the damage even with drug therapy
Severe limitation of the field of vision
Glaucoma is a disease related to too high pressure in the eye which causes a progressive loss of peripheral vision.
It is the second leading cause of blindness globally after cataracts. In Italy it affects about one million people but half of them would not be aware of it because they do not carry out periodic eye examinations.
The visual impairment caused by glaucoma can be prevented as long as the disease is diagnosed and treated promptly. This condition usually strikes after the age of 40.
The damage caused by glaucoma has until now been considered irreversible.
Under normal conditions inside the eye there is a liquid called aqueous humor which is continuously produced and reabsorbed, if the outflow path is blocked there will be an increase in pressure inside the eyeball.
The increase in pressure damages the neurons that carry images to the brain, whoever is sick continues to see the object they are staring at, but does not notice that the peripheral visual area is progressively decreasing.
In the more advanced stages the damage does extends to the central area of the visual field and, if glaucoma is not treated successfully, visual acuity is reduced up to complete blindness.
The open-angle shape is the most frequent and is caused by an obstacle encountered by the aqueous humor in its outflow.
It develops slowly and usually has no symptoms, so you may only realize you are ill when the damage to the optic nerve has already reached an advanced stage. Therefore it is advisable to undergo periodic eye checks.
In the angle-closure form, the iris can suddenly close the "drain", causing a rapid increase in intraocular pressure.
The acute glaucoma attack can cause blurring of vision, eye pain, headache and vomiting. If treated promptly, the consequences may not even be serious.
Since early diagnosis is essential, it is important to undergo periodic eye checks after the age of 40 and in the presence of a family history of glaucoma.
The tests necessary for a correct diagnosis are:
- Eye pressure measurement
- Computerized visual field
- Fundus examination
- OCT (Optical Coherence Tomography)
Currently the only possible treatment for glaucoma is to lower eye pressure through the use of eye drops to be instilled daily or with SLT laser therapy, unfortunately it is often not sufficient to stop the damage, particularly if in an advanced stage.
What do the clinical studies say?
Visual field loss is considered irreversible. Transorbital alternating current electrical stimulation (rtACS) was applied to patients with field damage to achieve functional recovery.
A double-blind, randomized, control group study was conducted with daily applications of rtACS (n=45) or placebo stimulation (n=37) for 50 minutes on 10 working days. The mean age of the patients is 59.1 years. Treatment efficacy was measured by suprathreshold visual field 48 hours after the last of ten treatments and three months later.
The rtACS-treated group showed an average visual field improvement of 24%, significantly better than the control group (2.5%).
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156134
Eyetronic is available at
I want to receive more information about Eyetronic
​https://eyetronic-therapie.de/en/
Page intended for healthcare professionals.
In compliance with the provisions provided by the Ministry of Health regarding health advertising relating to medical devices, in vitro diagnostic medical devices and medical-surgical aids, we inform you that the contents of this page are intended exclusively for healthcare professionals. Where present, the description of the products is for informational purposes only and is not intended for promotion of the same.
English 
Italian 
French 
Spanish 
German 
Chinese 
Korean 
Japanese